<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Document</title>

    <link rel="stylesheet" href="./test.css">
</head>
<body>
    <section class="team-section">
  <div class="container">
    <h2>Senior Leadership & MANAGEMENT TEAM</h2>
    <ul class="team-list">
      <li>
        <span class="name">Dr. Niranjan Kumar</span>, Chairman & CEO
      </li>
      <li>
        <span class="name">Ms. Jennifer L Sabatini</span>, Organizational Leadership
      </li>
      <li>
        <span class="name">Mr. Patkar, JMD</span>, Marketing Domestic & Worldwide Operations
      </li>
      <li>
        <span class="name">Mr. Mohammed M. HAMID</span>, Engineering, MENA BUSINESS DEVELOPMENT
      </li>
    </ul>

    <h2>Scientific & Technical Advisory Team</h2>
    <ul class="team-list">
      <li>
        <span class="name">Dr. Eric F. Bernstein, MD, EMTM</span>
      </li>
      <li>
        <span class="name">Dr. Rajesh Gupta</span>, US-FDA, Biologics Consultant
      </li>
      <li>
        <span class="name">Dr. Jinyou Zhang, Ph.D</span>, AVP, Immunomedics, NJ, USA
      </li>
      <li>
        <span class="name">Dr. Eugene Mensah, Ph.D, MBA</span>, Toshiba Medical Research Institute, USA
      </li>
      <li>
        <span class="name">Mr. Venkatadri Bobba, M.Pharm, MBA</span>, Principal, Venture East, USA
      </li>
    </ul>

    <h2>Bios of ABSN Founding Directors</h2>
    <div class="bios-group">
      <div class="bio">
        <h3>Dr. Niranjan Kumar, Ph.D.</h3>
        <p>
          Expert in Biochemistry & Microbiology.<br>
          Fellowship: American Thoracic Society, Moore Technology Management (UPENN Engineering, Wharton School), USP Expert Committee, Six Sigma Black Belt.<br>
          Over 22 years experience in Biologics, vaccines, biotherapeutics, regulatory affairs and strategic partnerships. Leadership roles in Wockhardt Biotech, Sanofi-Aventis, Novavax Inc. USA, Wyeth-Lederle, Merck, and academia. Managed product launches, method validation, CMC, cross-functional biotech business, and published 51+ manuscripts.<br>
        </p>
      </div>
      <div class="bio">
        <h3>Dr. Madhavan P.N. Nair, Ph.D., C.N.S., F.A.C.N., F.A.A.A.I.</h3>
        <p>
          Founding Director of ABS Inc. USA and AM Pharmaceutical Solutions.<br>
          Professor & Chair in Immunology; academic leader in R&D, clinical nutrition, neuro-immunology, cancer and allergy studies; 100+ publications, 3 patents; NIH Principal Investigator with $17M in funding; advisor to health and pharma companies US and India.<br>
        </p>
      </div>
      <div class="bio">
        <h3>Ms. Geetha Kumar Merakanapalli, BS, MBA</h3>
        <p>
          25+ years of accounting and finance management and customer service. Managed US pharmaceutical companies including Parr Pharmaceuticals, ABS Inc., and AMPSI.<br>
        </p>
      </div>
    </div>
  </div>
</section>

</body>
</html>